🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Published 02/01/2024, 11:40
Updated 02/01/2024, 13:10
© Reuters.  $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
GSAT
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

The Dow Jones index closed lower by around 20 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Retractable Technologies

  • The Trade: Retractable Technologies, Inc. (NYSE: RVP) President and CEO Thomas J Shaw acquired a total of 3,455 shares an average price of $1.07. To acquire these shares, it cost around $3,703.
  • What’s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.
  • What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.
Athira Pharma
  • The Trade: Athira Pharma, Inc. (NASDAQ: ATHA) Director Joseph Edelman acquired a total of 605,686 shares at an average price of $2.42. To acquire these shares, it cost around $1.46 million.
  • What’s Happening: Athira Pharma, last month, announced results from SHAPE Phase 2 clinical trial of fosgonimeton for the treatment of Parkinson's disease dementia and dementia with Lewy Bodies.
  • What Athira Pharma Does: Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration.
Check This Out: How To Earn $500 A Month From Annaly Capital Management Stock

Globalstar

  • The Trade: Globalstar, Inc. (NYSE: GSAT) Director James F Lynch acquired a total of 500,000 shares at an average price of $1.73. The insider spent around 863,800 to buy those shares.
  • What’s Happening: On Nov. 2, Globalstar reported third-quarter FY23 sales growth of 53% year-on-year to $57.7 million.
  • What Globalstar Does: Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services.
Collective Audience
  • The Trade: Collective Audience, Inc. (NASDAQ: CAUD) Director Nadine Watt acquired a total of 10,000 shares at an average price of $1.50. The insider spent around $14,988 to buy those shares.
  • What’s Happening: Collective Audience, last month, appointed Peter Bordes, as Chief Executive Officer.
  • What Collective Audience Does: Collective Audience Inc is a provider of e-commerce and digital customer acquisition solutions by simplifying digital advertising.

Don’t forget to check out our premarket coverage here

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.